Malignant neoplasm of overlapping sites of breast
Conditions
Interventions
This is a randomized controlled clinical trial with two groups, open-label (no masking), with participant allocation performed by computer-generated random draw, in a one-to-one ratio. A total of 39 w
E02.760.169.063.500.387.875
G11.427.410.698.277
Sponsors
Hospital da Mulher Professor Doutor José Aristodemo Pinotti - Centro de Atenção Integral à Saúde da Mulher da Universidade Estadual de Campinas
Universidade Estadual de Campinas
Eligibility
Sex/Gender
Female
Age
No minimum to 65 Years
Inclusion criteria
Inclusion criteria: Women up to 65 years old; previous breast cancer diagnosis; adjuvant or neoadjuvant chemotherapy performed; exclusive adjuvant endocrine therapy between 6 and 36 months; no evidence of disease
Exclusion criteria
Exclusion criteria: Presence of metastasis; inability to answer questionnaires; inability to perform the initial physical assessment; lack of physical condition to perform exercises; unavailability to participate in the online training program
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: It is expected to find, from baseline to after 12 weeks of intervention, an increase in lean mass, with a greater magnitude of response in the supervised online training group compared to the non-supervised training group, assessed by dual-energy X-ray absorptiometry (DEXA);Observed outcome 1: It was observed, from baseline to after 12 weeks of intervention, an increase of approximately 3% in lean mass in the supervised online training group, while no increase was observed in the non-supervised training group, assessed by dual-energy X-ray absorptiometry (DEXA) | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 2: It is expected to find, from baseline to after 12 weeks of intervention, a reduction in fat mass, with a greater magnitude of response in the supervised online training group compared to the non-supervised training group, assessed by dual-energy X-ray absorptiometry (DEXA);Observed outcome 2: It was observed, from baseline to after 12 weeks of intervention, a reduction of approximately 3.69% in fat mass in the supervised online training group, while an increase of approximately 0.28% was observed in the non-supervised training group, assessed by dual-energy X-ray absorptiometry (DEXA);Expected outcome 3: It is expected to find, from baseline to after 12 weeks of intervention, an increase in lower body strength, with a greater magnitude of response in the supervised online training group compared to the non-supervised training group, assessed by the one-repetition maximum test (1RM) in the leg press exercise;Observed outcome 3: It was observed, from baseline to after 12 weeks of intervention, an increase of approximately 28.42% in lower body strength in the supervised online training group, while an increase of approximately 12.11% was observed in the non-supervised training group, assessed by the one-repetition maximum test (1RM) in the leg press exercise;Expected outcome 4: It is expected to find, from baseline to after 12 weeks of intervention, an increase in handgrip strength, with a greater magnitude of response in the supervised online training group compared to the non-supervised training group, assessed by handgrip dynamometry;Observed outcome 4: It was observed, from baseline to after 12 weeks of intervention, an increase of approximately 7.85% in handgrip strength in the supervised online training group, while an increase of approximately 5.93% was observed in the non-supervised training group, assessed by handgrip dynamometry;Expected outcome 5: It is expected to find, from baseline to after 12 weeks of intervention, an increase in card | — |
Countries
Brazil
Contacts
Public ContactHenrique Bortolozo
Universidade Estadual de Campinas
Outcome results
None listed